Exhibit 10.1
Execution Copy
This AMENDING AGREEMENT is dated as of September 25, 2020.
AMONG:
AMALGO CORPORATION (formerly Neograft Solutions Inc., the entity existing following the amalgamation of NeoGraft Solutions Inc., NeoGrafters Limited, and 1904247 Ontario Ltd.), (“Canadian Vendor Amalco”), a corporation existing under the laws of the Province of Ontario
– and –
AMALGO HOLDING CORP. (formerly NeoGraft Holding Corp.), a corporation existing under the laws of the State of Delaware (“Holdings US”)
– and –
AMALGO SOLUTIONS CORP. (formerly NeoGraft Solutions Corp.), a corporation existing under the laws of the State of Delaware (“Solutions US”)
– and –
AMALGO US CORP. (formerly NeoGrafters US Corp.), a corporation existing under the laws of the State of Delaware (“Grafters US” and together with Holdings US and Solutions US, the “US Vendors”)
– and –
AMALGO (formerly Societe De Promotion Et Diffusion D’equipement Medical Medicamat), a corporation existing under the laws of France (the “French Vendor” and together with Canadian Vendor Amalco and the US Vendors, the “Vendors”)
– and –
MIRIAM MERKUR, an individual resident in the Province of Ontario (“Miriam” and collectively with the Vendors, the “Vendor Parties”)
– and –
VENUS CONCEPT LTD., a corporation existing under the laws of Israel (the “Purchaser”)
WHEREAS the Vendor Parties and the Purchaser are parties to a master asset purchase agreement dated as of January 26, 2018 (the “MAPA”);
AND WHEREAS in accordance with the terms of Section 2.10 of the MAPA the Purchaser has paid Canadian Vendor Amalco an aggregate of $1,203,376.07 of the Earn-Out Amount;
AND WHEREAS the Parties desire to amend the terms of the MAPA in accordance with Section 1.12 of the MAPA to establish a payment plan for the remaining portion of the Earn-Out Amount, such amount being $796,623.93 (the “Earn Out Balance”), to be paid by the Purchaser to Canadian Vendor Amalco as set forth herein;